MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 1489

Keywords: Behavioral abnormalities, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Psychiatric manifestations

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We aimed to explore different aspects of action control, assessing reward-related behaviour, inhibition (externally and internally triggered) and sense of agency in Parkinson’s disease (PD) patients, with and without impulsive-compulsive behaviours (ICB) compared to a group of healthy subjects.

Background: Pathophysiology of ICB in PD is poorly understood. Most previous research focussed on reward-related processing in the brain. However, other aspects of volitional control of action may be important in the pathophysiology of ICB, such as sense of agency for action and action inhibition.

Methods: Thirty-eight PD patients (19 with and 19 without ICB) and 19 healthy subjects (HS) were included in the study. Subjects underwent a short test battery covering key components of voluntary action, including: Intentional Binding task which measures experience of agency; the Marble task, which measures the sequential balance between action and inhibition in intentional self-control; Stop signal reaction time which measures capacity for reactive inhibition; Balloon Analog Risk Task which measures reward sensitivity by titrating reward against risk.

Results: When comparing the degree of binding effects among groups, one way ANOVA showed a significant main effect of group for action binding (p= 0.004, F=6.27). Post hoc analysis revealed that PD-ICB showed significantly stronger action binding than HS (p=0.004), and than PD-no-ICB (p=0.04) [figure1]. There was no difference between PD-no-ICB and HS. A significant difference between PD-no-ICB and HC was detected in quantile SSRT (p=0.008). No other significant differences were found among groups in the other tasks.

Conclusions: PD patients with ICB have abnormal performance on a task of action binding compared to PD patients without ICB and healthy subjects. They appear to have a weak experience of their own volitional actions. They had no deficit on tasks evaluating externally and internally triggered inhibitory control, or in reward-based decision-making. Thus, we conclude that PD patients with ICB have a deficit in action representation at the cognitive/experiential level. This result opens new perspective on the pathophysiological basis of ICB deficits, and on the future therapeutic management of them.

To cite this abstract in AMA style:

L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards. Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/volition-and-action-control-in-parkinsons-disease-patients-with-impulsive-compulsive-behaviour-disorders/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/volition-and-action-control-in-parkinsons-disease-patients-with-impulsive-compulsive-behaviour-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley